EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Blood–Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems

Yanan He, Mengyao Qu, Lu Yu, Lipeng He, Yixun Lu, Jin Hong, Miao Sun, Huikai Yang, Weidong Mi, Hang Guo, Yulong Ma iD

MedComm · 2026-04 · 7 (4)

DOI: 10.1002/mco2.70712 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 01.04.2026. Verfasst von Yanan He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology The First Medical Center of Chinese PLA General Hospital Beijing China. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blood–brain barrier (BBB) is a highly selective and dynamic neurovascular interface essential for maintaining central nervous system homeostasis. This specialized barrier comprises brain microvascular endothelial cells interconnected by tight junctions, supported by pericytes and astrocytic end‐feet within the neurovascular unit. While protecting the brain from circulating pathogens and toxins, the BBB presents formidable obstacles to drug delivery, restricting approximately 98% of small‐molecule therapeutics and nearly all large biomolecules from reaching the brain parenchyma. BBB dysfunction is critically implicated in the pathogenesis and progression of numerous neurological disorders, including ischemic stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and brain tumors. This comprehensive review systematically examines the structural organization and functional characteristics of the BBB, elucidates its pathophysiological roles across major neurological diseases, and critically evaluates innovative drug delivery strategies designed to overcome this biological barrier. We analyze passive targeting approaches, active targeting mechanisms via receptor‐mediated transcytosis, and stimuli‐responsive systems including focused ultrasound and magnetic guidance. Additionally, we discuss multifunctional nanoplatforms, biomimetic cell membrane‐coated delivery systems, current preclinical evidence, and clinical translation challenges. Finally, we propose future research directions and identify specific experimental pathways to accelerate the development of next‐generation BBB‐targeted therapeutics from preclinical promise to clinical application.

Schlagwörter

Stichwörter der Autor:innen

blood–brain barrierdrug delivery systemsischemic strokenanoparticlesneurological diseasesneurovascular unittargeted therapy

Autor:innen und Institutionen

  • Department of Anesthesiology The First Medical Center of Chinese PLA General Hospital Beijing China.
  • School of Chemistry and Materials Science Anhui Normal University Wuhu China.
  • Department of Anesthesiology The Seventh Medical Center of Chinese PLA General Hospital Beijing China.
  • The Second School of Clinical Medicine Southern Medical University Guangzhou China.

ORCID-Profile: Yulong Ma

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

He, Y., Qu, M., Yu, L., He, L., Lu, Y., Hong, J., Sun, M., Yang, H., Mi, W., Guo, H., & Ma, Y. (2026). Blood–Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems. MedComm, 7(4). https://doi.org/10.1002/mco2.70712

Vancouver

He Y, Qu M, Yu L, He L, Lu Y, Hong J, et al. Blood–Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems. MedComm. 2026;7(4). doi:10.1002/mco2.70712

BibTeX
@article{He2026,
  author = {He, Yanan and Qu, Mengyao and Yu, Lu and He, Lipeng and Lu, Yixun and Hong, Jin and Sun, Miao and Yang, Huikai and Mi, Weidong and Guo, Hang and Ma, Yulong},
  title = {Blood–Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {4},
  doi = {10.1002/mco2.70712}
}
Kostenlos starten →